M&A Transaction

P&G Acquires Thorne for $3.8B in Wellness Push

Procter & Gamble buys Thorne for $3.8B, boosting its health portfolio and delivering a significant exit for L Catterton in the booming wellness market.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Consumer, Healthcare, Healthtech & Medtech in United States" are published.

Key Takeaways

  • Procter & Gamble acquired Thorne, L Catterton for $3.8B.
  • Sector: Consumer, Healthcare, Healthtech & Medtech.
  • Geography: United States.

Analysis

Procter & Gamble is significantly expanding its footprint in the booming health and wellness sector with a definitive agreement to acquire Thorne for $3.8 billion in an all-cash transaction. This strategic move injects a premium nutritional supplement brand into P&G's established health division, which already includes well-known names like New Chapter, Metamucil, and Align Probiotic.

The acquisition represents a substantial payday for private equity firm L Catterton, which is exiting its investment in Thorne just three years after taking the company private. L Catterton is anticipated to realize a return exceeding $3 billion on its initial investment, acquired for approximately $680 million in 2023. This swift and profitable exit underscores the significant value creation achievable within the health and wellness segment, particularly for businesses with strong brand recognition and growth potential.

The health and supplements market, valued at over $150 billion globally and projected to grow at a CAGR of 8-10%, is experiencing robust demand. Consumers are increasingly prioritizing preventative healthcare and self-care, driving sustained interest in nutritional products. P&G's acquisition of Thorne aligns perfectly with this trend, allowing the consumer goods giant to capture a larger share of this high-growth category and leverage Thorne's established reputation for quality and efficacy.

Thorne, a company recognized for its science-backed approach to supplements, has demonstrated impressive growth since L Catterton's investment. Industry observers indicate the company is on track to generate approximately $650 million in revenue this year. This performance highlights the success of L Catterton's strategy to accelerate Thorne's expansion within the premium supplements market. Raj Shah, a Partner at L Catterton, expressed confidence that P&G is well-equipped to continue Thorne's growth trajectory.

This deal is indicative of a broader industry consolidation, as major consumer packaged goods companies actively seek to enhance their portfolios with offerings in higher-growth wellness categories. Competitors are also making strategic moves; earlier this year, Unilever acquired Gruns, and Nestlé has been evaluating its own vitamin and supplement divisions. The strong interest Thorne attracted from multiple strategic buyers prior to this agreement further validates the appeal of scaled health and wellness businesses with robust growth profiles.

For Procter & Gamble, integrating Thorne offers a dual benefit: immediate expansion into a lucrative market and the potential to cross-promote within its existing health and wellness brands. This acquisition solidifies P&G's commitment to diversifying its revenue streams and capitalizing on evolving consumer preferences for health-conscious products. The transaction is expected to close in the coming months, subject to customary closing conditions.